Manganese transport disorder: Novel SLC30A10 mutations and early phenotypes

SLC30A10 mutations cause an autosomal recessive disorder, characterized by hypermanganesaemia, polycythemia, early‐onset dystonia, paraparesis, or late‐onset parkinsonism, and chronic liver disease. This is the first identified inborn error of Mn metabolism in humans, reported in 10 families thus far.

[1]  P. Clayton,et al.  Dystonia/Parkinsonism, Hypermanganesemia, Polycythemia, and Chronic Liver Disease , 2014 .

[2]  M. Aschner,et al.  Genetic factors and manganese-induced neurotoxicity , 2014, Front. Genet..

[3]  Philip A. Huebner,et al.  Pathology of inherited manganese transporter deficiency , 2014, Annals of neurology.

[4]  Aart J. Nederveen,et al.  Functional MRI study of response inhibition in myoclonus dystonia , 2013, Experimental Neurology.

[5]  S. Lehéricy,et al.  The anatomical basis of dystonia: Current view using neuroimaging , 2013, Movement disorders : official journal of the Movement Disorder Society.

[6]  B. P. Warrenburg,et al.  Phenotypic variability in a dystonia family with mutations in the manganese transporter gene , 2013, Movement disorders : official journal of the Movement Disorder Society.

[7]  A. Burroughs,et al.  Dystonia with Brain Manganese Accumulation Resulting From SLC30A10 Mutations: A New Treatable Disorder , 2012, Movement disorders : official journal of the Movement Disorder Society.

[8]  B. Oostra,et al.  Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. , 2012, American journal of human genetics.

[9]  R. Wevers,et al.  Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. , 2012, American journal of human genetics.

[10]  K. Gordon,et al.  Manganese Toxicity in a Child With Iron Deficiency and Polycythemia , 2011, Journal of child neurology.

[11]  M. Bitner-Glindzicz,et al.  Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia—A new metabolic disorder , 2008, Journal of Inherited Metabolic Disease.

[12]  S. Gospe,et al.  Paraparesis, hypermanganesaemia, and polycythaemia: a novel presentation of cirrhosis , 2000, Archives of disease in childhood.

[13]  D. Guehl,et al.  Movement disorders induced by gamma-aminobutyric agonist and antagonist injections into the internal globus pallidus and substantia nigra pars reticulata of the monkey , 1998, Brain Research.

[14]  M. Goldberg,et al.  Regulation of the erythropoietin gene , 1993, Blood.

[15]  A. Federico,et al.  Two-year follow-up after chelating therapy in a patient with adult-onset parkinsonism and hypermanganesaemia due to SLC30A10 mutations , 2013, Journal of Neurology.

[16]  J. Roth.  Homeostatic and toxic mechanisms regulating manganese uptake, retention, and elimination. , 2006, Biological research.

[17]  G. E. Alexander,et al.  Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. , 1990, Progress in brain research.